Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (261-270 of 382) with videos related to

Pageof 39
Sort By:
Scientific Reports|February 15, 2017
The alternative complement pathway is dysregulated in patients with chronic heart failureNegar Shahini, Annika E Michelsen, Per H Nilsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2026
Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI TrialThor Ueland, Tuva B Dahl, Annika Michelsen, et al.
Circulation. Heart Failure|October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant RecipientsSatish Arora, Arne K Andreassen, Kristjan Karason, et al.
International Journal of Cardiology|October 11, 2012
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarctionLars Gullestad, Stein Orn, Kenneth Dickstein, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 3, 2017
Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humansArkady Rutkovskiy, Julia Sagave, Gabor Czibik, et al.
British Journal of Clinical Pharmacology|November 21, 2013
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysisCatherine Cornu, Christophe Dufays, Ségolène Gaillard, et al.
Cardiovascular Research|March 15, 2008
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statinsCamilla Smith, Bente Halvorsen, Kari Otterdal, et al.
Basic Research in Cardiology|July 11, 2012
Aquaporin-4 in the heart: expression, regulation and functional role in ischemiaArkady Rutkovskiy, Kåre-Olav Stensløkken, Lars Henrik Mariero, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 11, 2017
Prognostic Value of Left Ventricular Deformation Parameters in Patients with Severe Aortic Stenosis: A Pilot Study of the Usefulness of Strain EchocardiographyLars Gunnar Klaeboe, Trine F Haland, Ida S Leren, et al.
Pageof 39

Showing results (261-270 of 382) with videos related to

Sort By:
Pageof 39
Scientific Reports|February 15, 2017
The alternative complement pathway is dysregulated in patients with chronic heart failureNegar Shahini, Annika E Michelsen, Per H Nilsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2026
Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI TrialThor Ueland, Tuva B Dahl, Annika Michelsen, et al.
Circulation. Heart Failure|October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant RecipientsSatish Arora, Arne K Andreassen, Kristjan Karason, et al.
International Journal of Cardiology|October 11, 2012
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarctionLars Gullestad, Stein Orn, Kenneth Dickstein, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 3, 2017
Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humansArkady Rutkovskiy, Julia Sagave, Gabor Czibik, et al.
British Journal of Clinical Pharmacology|November 21, 2013
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysisCatherine Cornu, Christophe Dufays, Ségolène Gaillard, et al.
Cardiovascular Research|March 15, 2008
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statinsCamilla Smith, Bente Halvorsen, Kari Otterdal, et al.
Basic Research in Cardiology|July 11, 2012
Aquaporin-4 in the heart: expression, regulation and functional role in ischemiaArkady Rutkovskiy, Kåre-Olav Stensløkken, Lars Henrik Mariero, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 11, 2017
Prognostic Value of Left Ventricular Deformation Parameters in Patients with Severe Aortic Stenosis: A Pilot Study of the Usefulness of Strain EchocardiographyLars Gunnar Klaeboe, Trine F Haland, Ida S Leren, et al.
Pageof 39